Effect of PGE1 on TNF-α status and hepatic D-galactosamine-induced apoptosis in rats

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 2, 1998, Pages 197-207

  Muntané, Jordi ^a   Montero, Jose Luis ^a   Marchal, Trinidad ^a   Perez Seoane, Carlos ^a   Lozano, Jose Manuel ^a   Fraga, Enrique ^a   Pintado, Carmelo Oscar ^a   De La Mata, Manuel ^a   Miño, Gonzalo ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Aminotransferase; Apoptosis; D galactosamine; Fulminant hepatic failure; Rat; TNF

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GALACTOSAMINE; PROSTAGLANDIN E1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD ANALYSIS; CELL DIVISION; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GEL ELECTROPHORESIS; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER FAILURE; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL CYCLE; COMPARATIVE STUDY; DRUG EFFECT; LIVER; METABOLISM; PATHOLOGY; TOXIC HEPATITIS; WISTAR RAT;

ALPROSTADIL; ANIMALS; APOPTOSIS; CELL CYCLE; GALACTOSAMINE; HEPATITIS, TOXIC; LIVER; MALE; MICROSCOPY, ELECTRON; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031593299     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00638.x     Document Type: Article

References (47)

1. Keppler D, Lesch R, Reutter W, Decker K. Experimental hepatitis induced by D-galactosamine. Exp. Mol. Pathol. 1968; 9: 279-90.
2. Decker K, Keppler D. Galactosamine-induced liver injury. In: Popper H, Schaffner F, eds. Progress in Liver Disease (Vol. 4). New York: Grune and Stratton, 1972; 183-96.
3. Dixit V, Chang TMS. Effects of prostaglandin E on brain edema and liver histopathology in a galactosamine-induced fulminant hepatic failure rat model. Biomat. Artif. Cells Artif. Organs 1987; 15: 559-73.
4. Bergasa NV, Borque MJ, Wahl LM, Rabin L, Jones EA. Modulation of thioacetamide-induced hepatocellular necrosis by prostaglandins is associated with novel histologic changes. Liver 1992; 12: 168-74.
5. Rush BD, Wilkinson KF, Nichols NM, Ochoa R, Brunden MN, Ruwart MJ. Hepatic protection by 16,16-dimethyl prostaglandin E. (DMPG) against acute aflatoxin B-induced injury in the rat. Prostaglandins 1989; 37: 683-93.
6. Stachura J, Tarnawski A, Ivey KJ et al. Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology 1981; 81: 211-7.
7. Beck PL, Mcknight GW, Kelly JK, Wallace JL, Lee SS. Hepatic and gastric cytoprotective effects of long-term prostaglandin E, administration in cirrhotic rats. Gastroenterology 1993; 105: 1483-9.
8. Ruwart MJ, Rush BD, Snyder KF, Peters KM, Appelman HD, Henley KS. 16,16-dimethyl E delays collagen formation in nutritional injury in rat liver. Hepatology 1988; 8: 61-4.
9. Abecassis M, Falk JA, Makowka L, Dindzans VJ, Falk RE, Levy GA. 16, 16 dimethyl prostaglandin E prevents the development of fulminant hepatitis and blocks the induction of monocyte macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J. Clin. Invest. 1987; 80:881-9.
10. Kurebayashi Y, Honda Y. Protection by 16, 16-dimethyl prostaglandin E and dibutyryl cyclic AMP against complement-mediated hepatic necrosis in rats. Hepatology 1991; 14: 545-50.
11. Sinclair SB, Greig PD, Blendis LM et al. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. J. Clin. Invest. 1989; 84: 1063-9.
12. Sinclair SB, Levy GA. Treatment of fulminant viral hepatic-failure with prostaglandin E. A preliminary report. Dig. Dis. Sci. 1991; 36: 791-800.
13. Noda Y, Hughes RD, Williams R. Effect of prostacyclin (PGI) and a prostaglandin analogue BW 245C on galactosamine-induced hepatic necrosis. J. Hepatol. 1986; 2: 53-64.
14. Limm SP, Andrews FJ, Christophi C, O'Brien PE. Microvascular changes in liver after ischemia-reperfusion injury. Dig. Dis. Sci. 1994; 39: 1683-90.
15. Masaki N, Ohta Y, Shirataki H et al. Hepatocyte membrane stabilization by prostaglandins E and E : favorable effects on rat injury. Gastroenterology 1992; 102: 572-6.
16. Marinovich M, Flaminio LM, Pagani M, Galli CL. Stimulation of arachidonic acid metabolism by CCl, in isolated rat hepatocytes. Prostaglandins 1989; 37: 23-31.
17. Michie HR, Manogue KR, Spriggs DR et al. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 1988; 318: 1481-6.
18. Tiegs G, Wolter M, Wendel A. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem. Pharmacol. 1989; 38: 627-31.
19. Mahl TC, Tzung SP, Lance P, Andersen V, Cohen SA. Prostaglandin E inhibits tumor necrosis factor production by kupffer cells and prevents endotoxin induced mortality in mice. Gastroenterology 1992; 102: A846.
20. Darzynkiewicz Z, Li X, Gong J. Assays of cell viability: discrimination of cells dying by apoptosis. In: Darzynkiewicz Z, Robinson JP, Crissman HA, eds. Methods in Cell Biology. Flow Cytometry (Vol. 41). San Diego: Academic Press, 1994; 15-38.
21. Reithman S, Frankel D. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvate transaminase. Am. J. Clin. Pathol. 1957; 28: 56-63.
22. Ryan CJ, Aslam M, Courtney JM. Transference of hepatic coma to normal rats from galactosamine treated donors by reverse plasma exchange. Biomat. Art. Cells Art. Org. 1990; 18: 477-82.
23. Mihas AA, Ceballos R, Mihas TA, Hirschowitz BI. Modification of the hepatotoxicity of D-galactosamine in the rat by an anti-endotoxin. J. Med. 1990; 21: 301-11.
24. Ellis RE, Yuan J, Horvitz HR. Mechanism and functions of cell death. Annu. Rev. Cell. Biol. 1991; 7: 663-98.
25. Rosser BG, Gores GJ. Liver cell necrosis: Cellular mechanisms and clinical implications. Gastroenterology 1995; 108: 252-75.
26. Ando K, Moriyama T, Guidotti LG et al. Mechanism of class I restricted immunopathology, a transgenic mouse model of fulminant hepatitis. J. Exp. Med. 1993; 178: 1541-54.
27. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J. Immunol. 1994; 153: 1778-88.
28. Faa G, Ambu T, Congiu T et al. Early ultrastructural changes during thioacetamide-induced apoptosis in rat liver. J. Submicrose. Cytol. Pathol. 1992; 24: 417-24.
29. Ledda-Columbano GM, Coni P, Curto M et al. Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. Am. J. Pathol. 1991; 139: 1099-109.
30. Schulte-Hermann R, Grasl-Kraupp B, Bursch W. Apoptosis and hepatocarcinogenesis. In: Jirtle RL, ed. Liver Regeneration and Carcinogenesis. San Diego: Academic Press, 1995; 141-77.
31. Leist M, Gantner F, Jilg S, Wendel A. Activation of the 55 KDaTNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 1995; 154: 1307-16.
32. Nagaki M, Muto Y, Ohnishi H et al. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology 1994; 106: 450-8.
33. Gantner F, Uhlig S, Wendel A. Quinine inhibits release of tumor necrosis factor, apoptosis and mortality in a murine model of septic liver failure, Eur. J. Pharmacol. 1995; 294: 353-61.
34. Zmiec Z, Hughes RD, Moore KP et al. Effect of supernatant from kupffer cells stimulated with galactosamine and endotoxin on the function of isolated rat hepatocytes. Hepatogastroenterology. 1993; 40: 259-61.
35. Skouteris GG, Ord MG, Stocken LA. Regulation of the proliferation of primary rat hepatocytes by eicosanoids. J. Cell. Physiol. 1988; 135: 516-20.
36. Refsnes M, Thoresen GH, Dajani, Christoffersen T. Stimulation of hepatocyte DNA synthesis by prostaglandin E. and prostaglandin F.: additivity with the effect of norepinephrine, and synergism with epidermal growth factor. J. Cell. Physiol. 1994; 159: 35-40.
37. Matsumoto M, Kikuchi E, Okamolo Y et al. D-galactosamine-induced cell damage enhances specific binding of prostaglandin E, to rat hepatocytes. Biochem. Biophys. Res. Commun. 1992; 184: 654-60.
38. Hashimoto N, Watanabe T, Ikeda Y et al. Down-regulation of prostaglandin E receptors in regenerating rat liver and its physiological significance. Biochem. Biophys. Res. Commun. 1991; 176: 226-32.
39. Karck U, Peters T, Decker K. The release of tumor necrosis factor from endotoxin-stimulated rat kupffer cells is regulated by prostaglandin E and dexamethasone. J. Hepatol. 1988; 7: 352-61.
40. Tran-thi TA, Decker K, Baeuerle PA. Differential activation of transcription factors NF-kappa B and AP-1 in rat liver macrophages. Hepatology 1995; 22: 613-19.
41. Grewe M, Gausling R, Gyufko K, Hoffmann R, Decker K. Regulation of the mRNA expression for tumor necrosis factor-alpha in rat liver macrophages. J. Hepatol. 1994; 20: 811-18.
42. Pruimboom WM, Van Dijk JA, Tak CJ et al. Interactions between cytokines and eicosanoids: a study using human peritoneal macrophages. Immunol. Lett. 1994; 41: 255-60.
43. Fieren MW, Van Den Bemd GJ, Ben-Efraim S, Bonta IL. Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages. Imnmnol. Lett. 1992; 31: 85-90.
44. 4 and PAF. Mediat. Inflamm. 1992; 1: 5-8.
45. Renz H, Gong J, Schmidt A, Nain M, Gemsa D. Release of tumor necrosis factor-α from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E, and cyclic nucleotides. J. Imnnmol. 1988; 141: 2388-93.
46. Kubo Y, Yasunaga M, Masuhara M, Teral S, Nakamura T, Okita K. Hepatocyte proliferation induced in rats by lead nitrate is suppressed by several tumor necrosis factor α inhibitors. Hepatology 1996; 23: 104-14.
47. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptor circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor-α in vitro and in vivo. Proc. Natl Acad. Sci. USA 1992; 89: 4845-9.